|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.820 SEK | +5.57% |
|
+11.62% | +21.79% |
| 07-08 | Mendus Completes First Stage Recruitment for Vididencel Trial | MT |
| 07-08 | Mendus completes recruitment for the first part of the VITAL-CML study | FW |
Company Valuation: Mendus AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 854.4 | 480.6 | 451.4 | 392.9 | 342.9 | 418.4 | - | - |
| Change | - | -43.76% | -6.06% | -12.97% | -12.71% | 22.01% | - | - |
| Enterprise Value (EV) 1 | 735.8 | 490.7 | 331.5 | 291.8 | 279.1 | 97.1 | 221.4 | 418.4 |
| Change | - | -33.3% | -32.45% | -11.97% | -4.35% | -65.21% | 128.01% | 88.98% |
| P/E | -5.87x | -3.44x | -2.38x | -2.95x | -2.58x | -4.46x | -7.59x | - |
| PBR | - | - | - | 0.61x | 0.6x | 1.07x | 1.4x | - |
| PEG | - | 0.84x | 0x | 0.1x | 0.1x | 0.2x | 0.2x | - |
| Capitalization / Revenue | 27,562x | 142x | 15.2x | 77.8x | 43.4x | 46.7x | 1.86x | 53x |
| EV / Revenue | 23,735x | 145x | 11.2x | 57.8x | 35.3x | 10.8x | 0.99x | 53x |
| EV / EBITDA | -5.66x | -3.73x | -3.69x | -2.35x | -2.6x | -1x | 1.84x | -6.13x |
| EV / EBIT | -5.66x | -3.67x | -3.29x | -2.23x | -2.46x | -0.97x | 1.88x | -6.13x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -14.6 | -14 | -4.4 | -2.64 | -2.17 | -1.529 | -0.8985 | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.031 | 3.375 | 29.61 | 5.048 | 7.902 | 8.95 | 224.5 | 7.9 |
| EBITDA 1 | -130.1 | -131.5 | -89.78 | -124.2 | -107.2 | -97.14 | 120.6 | -68.2 |
| EBIT 1 | -130.1 | -133.7 | -100.6 | -130.7 | -113.5 | -100.2 | 117.6 | -68.2 |
| Net income 1 | -133.4 | -138.8 | -101.6 | -128.4 | -113.3 | -163 | -18.59 | -68.2 |
| Net Debt 1 | -118.6 | 10.19 | -119.9 | -101.1 | -63.81 | -321.3 | -197 | - |
| Reference price 2 | 85.700 | 48.200 | 10.460 | 7.801 | 5.600 | 6.820 | 6.820 | 6.820 |
| Nbr of stocks (in thousands) | 9,970 | 9,970 | 43,157 | 50,360 | 61,234 | 61,349 | - | - |
| Announcement Date | 2/17/22 | 2/17/23 | 2/14/24 | 2/13/25 | 2/11/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.46x | 10.85x | -1x | -.--% | 43.4M | |
| 35.38x | 6.18x | 19.12x | 0.93% | 50.73B | |
| -23.4x | 342.07x | -22.1x | -.--% | 39.73B | |
| 25.29x | 2.8x | 12.09x | -.--% | 34.69B | |
| 45.73x | 4.51x | 28.9x | -.--% | 33.21B | |
| 27.05x | 7.93x | 19.91x | 0.42% | 26.76B | |
| 31.75x | 5.12x | 23.32x | -.--% | 15.37B | |
| 23.95x | 2.04x | 8.96x | 1.12% | 13.78B | |
| 23.74x | 1.89x | 11.45x | -.--% | 12.85B | |
| Average | 20.56x | 42.60x | 11.19x | 0.27% | 25.24B | |
| Weighted average by Cap. | 22.49x | 63.81x | 11.59x | 0.32% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IMMU Stock
- Valuation Mendus AB
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
